Media Category: x - Recorded Webinars

16th of June 2020, Fifth ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised for the first time an interactive and fully digital learning experience. Here you can review the full webinar on Biomarkers in Ms & Epidemiology of MS. ABSTRACTSBIOMARKERS IN MSNIKOLAOS GRIGORIADISMultiple Sclerosis is an autoimmune, multifactorial disorder with its main hallmarks the persistent neuroinflammation and chronic neurodegeneration. Despite its extensive study, the lack of reliable and specific biomarkers for the disease makes it...

16th of June 2020, Fifth ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised for the first time an interactive and fully digital learning experience. Here you can review the full webinar on Progressive Forms of Multiple Sclerosis. Abstracts :CARLO POZZILLI & BART VAN WIJMEERSCHMultiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) and causes neurological impairment and disability. Progressive MS (PMS) is characterized by a continuous clinical deterioration without...

16th of June 2020, Fifth ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised for the first time an interactive and fully digital learning experience. Here you can review the full webinar on NMO spectrum disorders. Abstracts :NIKOLAOS GRIGORIADISDiagnostic errors may still common in Multiple Sclerosis (MS). In a number of cases where T2 lesions are identified in MRI may be considered as MS lesions resulting in inappropriate, sometimes harmful therapeutic interventions for the patient. Mono- or multi-focal symptoms consistent...

14th of March 2019, Fourth ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised an interactive learning and networking experience. Here you can review one of the two lectures that were on the agenda. ABSTRACTProf Ralf Ziemssen gave an introduction and his perspective on real world data in MS. What is it and why is it so important to collect them. And how real world evidence complements clinical trial data. TJALF ZIEMSSENProfessor Tjalf Ziemssen is Director of the Center of Clinical Neuroscience with its Multiple Sclerosis...